n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Corneal Neovascularization in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both NS-398 and indomethacin significantly inhibited corneal neovascularization with the % inhibition of 36." | 3.70 | The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat. ( Kawai, M; Kawai, Y; Mashima, Y; Yamada, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, M | 1 |
| Kawai, M | 1 |
| Kawai, Y | 1 |
| Mashima, Y | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Corneal Neovascularization
| Article | Year |
|---|---|
The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
Topics: Administration, Topical; Animals; Cornea; Corneal Neovascularization; Cyclooxygenase 2; Cyclooxygena | 1999 |